Literature DB >> 11115285

Salvage surgery after failure of nonsurgical therapy for carcinoma of the larynx and hypopharynx.

S J Stoeckli1, A B Pawlik, M Lipp, A Huber, S Schmid.   

Abstract

BACKGROUND: For larynx preservation, radiotherapy is gaining popularity for primary treatment of laryngeal and hypopharyngeal cancer, reserving surgery for salvage.
OBJECTIVE: To analyze the outcome of salvage surgery after failure of primary radiotherapy.
DESIGN: Nine-year retrospective outcome analysis.
SETTING: University referral center. PATIENTS: Fifty-four patients with squamous cell carcinoma of the larynx (n = 39) or hypopharynx (n = 15).
RESULTS: For laryngeal cancer, mean interval from radiation to detection of recurrence was 14.5 months (range, 2-66 months). Twenty-three patients (59%) presented with a more advanced tumor stage after radiation than at the initial evaluation. Total laryngectomy was needed in 36 patients (92%). Disease-specific 5-year survival rate was 63%. Survival of patients with small recurrent tumors was statistically significantly better than those with advanced tumors (P =.004). For hypopharyngeal cancer, mean interval from radiation to detection of the recurrence was 10.6 months (range, 3-40 months). Total laryngopharyngectomy was needed in 8 of 9 patients with local recurrrence; neck dissection, in 6 patients with regional recurrence. Disease-specific 5-year survival rate was only 20%. Recurrent tumor and node stages did not influence the outcome. Patients with regional recurrences did no better than those with local ones.
CONCLUSIONS: Salvage surgery in laryngeal cancer achieves good results, especially for small recurrences. Because of tumor progression, larynx preservation is seldom possible at the time of salvage. Salvage surgery in hypopharyngeal cancer shows poor survival regardless of tumor stage and despite radical surgical procedures, and can be recommended only for carefully selected patients. Arch Otolaryngol Head Neck Surg. 2000;126:1473-1477

Entities:  

Mesh:

Year:  2000        PMID: 11115285     DOI: 10.1001/archotol.126.12.1473

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  22 in total

1.  Management of the N0 neck in recurrent laryngeal squamous cell carcinoma.

Authors:  Pei-Jing Li; Wei-Han Hu; Ting Jin
Journal:  Mol Clin Oncol       Date:  2015-10-29

2.  Guidelines for the Surgical Management of Laryngeal Cancer: Korean Society of Thyroid-Head and Neck Surgery.

Authors:  Soon-Hyun Ahn; Hyun Jun Hong; Soon Young Kwon; Kee Hwan Kwon; Jong-Lyel Roh; Junsun Ryu; Jun Hee Park; Seung-Kuk Baek; Guk Haeng Lee; Sei Young Lee; Jin Choon Lee; Man Ki Chung; Young Hoon Joo; Yong Bae Ji; Jeong Hun Hah; Minsu Kwon; Young Min Park; Chang Myeon Song; Sung-Chan Shin; Chang Hwan Ryu; Doh Young Lee; Young Chan Lee; Jae Won Chang; Ha Min Jeong; Jae-Keun Cho; Wonjae Cha; Byung Joon Chun; Ik Joon Choi; Hyo Geun Choi; Kang Dae Lee
Journal:  Clin Exp Otorhinolaryngol       Date:  2017-01-03       Impact factor: 3.372

3.  Role of narrow-band imaging and high-definition television in the surveillance of head and neck squamous cell cancer after chemo- and/or radiotherapy.

Authors:  Cesare Piazza; Daniela Cocco; Luigi De Benedetto; Francesca Del Bon; Piero Nicolai; Giorgio Peretti
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-03-30       Impact factor: 2.503

4.  Outcomes of salvage surgery for the oropharynx and larynx: a contemporary experience in a UK Cancer Centre.

Authors:  Ashley Hay; Ricard Simo; Gillian Hall; Selvam Tharavai; Richard Oakley; Alastair Fry; Luke Cascarini; Mary Lei; Teresa Guerro-Urbano; Jean-Pierre Jeannon
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-01-21       Impact factor: 2.503

5.  Proportion of CD4 and CD8 tumor infiltrating lymphocytes predicts survival in persistent/recurrent laryngeal squamous cell carcinoma.

Authors:  Rebecca Hoesli; Andrew C Birkeland; Andrew J Rosko; Mohamad Issa; Kelsey L Chow; Nicole L Michmerhuizen; Jacqueline E Mann; Steven B Chinn; Andrew G Shuman; Mark E Prince; Gregory T Wolf; Carol R Bradford; Jonathan B McHugh; J Chad Brenner; Matthew E Spector
Journal:  Oral Oncol       Date:  2017-12-23       Impact factor: 5.337

6.  To do or not to do: salvage management for hypopharyngeal cancer after chemoradiation therapy.

Authors:  Pei-Hsin Chu; Ngan-Ming Tsang; Li-Ang Lee; Chun-Ta Liao; Tuan-Jen Fang
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-06-20       Impact factor: 2.503

7.  Methicillin Resistant Staphylococcus Aureus Infection as a causative agent of fistula formation following total laryngectomy for advanced head & neck cancer.

Authors:  Jean-Pierre Jeannon; Ahmad Orabi; Argyris Manganaris; Ricard Simo
Journal:  Head Neck Oncol       Date:  2010-06-28

8.  Salvage surgery after induction chemotherapy with paclitaxel/cisplatin and primary radiotherapy for advanced laryngeal and hypopharyngeal carcinomas.

Authors:  A Relic; M Scheich; J Stapf; C Voelter; F Hoppe; R Hagen; L Pfreundner
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-03-14       Impact factor: 2.503

9.  Management of recurrent head and neck cancer: variables related to salvage surgery.

Authors:  Laura Gañán; Montserrat López; Jacinto García; Eduard Esteller; Miquel Quer; Xavier León
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-05-17       Impact factor: 2.503

10.  Impact of FDG-PET on prediction of clinical outcome after concurrent chemoradiotherapy in hypopharyngeal carcinoma.

Authors:  Hidenori Inohara; Keisuke Enomoto; Yoichiro Tomiyama; Ichiro Higuchi; Takehiro Inoue; Jun Hatazawa
Journal:  Mol Imaging Biol       Date:  2009-05-07       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.